eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice by Li, Jie et al.
Li et al. Cell Death and Disease          (2019) 10:921 
https://doi.org/10.1038/s41419-019-2159-z Cell Death & Disease
ART ICLE Open Ac ce s s
eIF2α signaling regulates autophagy of osteoblasts
and the development of osteoclasts in OVX mice
Jie Li1,2, Xinle Li1,2, Daquan Liu1,2, Kazunori Hamamura3, Qiaoqiao Wan3, Sungsoo Na3, Hiroki Yokota3 and
Ping Zhang1,2,3,4
Abstract
Bone loss in postmenopausal osteoporosis is induced chiefly by an imbalance of bone-forming osteoblasts and bone-
resorbing osteoclasts. Salubrinal is a synthetic compound that inhibits de-phosphorylation of eukaryotic translation
initiation factor 2 alpha (eIF2α). Phosphorylation of eIF2α alleviates endoplasmic reticulum (ER) stress, which may
activate autophagy. We hypothesized that eIF2α signaling regulates bone homeostasis by promoting autophagy in
osteoblasts and inhibiting osteoclast development. To test the hypothesis, we employed salubrinal to elevate the
phosphorylation of eIF2α in an ovariectomized (OVX) mouse model and cell cultures. In the OVX model, salubrinal
prevented abnormal expansion of rough ER and decreased the number of acidic vesiculars. It regulated ER stress-
associated signaling molecules such as Bip, p-eIF2α, ATF4 and CHOP, and promoted autophagy of osteoblasts via
regulation of eIF2α, Atg7, LC3, and p62. Salubrinal markedly alleviated OVX-induced symptoms such as reduction of
bone mineral density and bone volume fraction. In primary bone-marrow-derived cells, salubrinal increased the
differentiation of osteoblasts, and decreased the formation of osteoclasts by inhibiting nuclear factor of activated
T-cells cytoplasmic 1 (NFATc1). Live cell imaging and RNA interference demonstrated that suppression of
osteoclastogenesis is in part mediated by Rac1 GTPase. Collectively, this study demonstrates that ER stress-autophagy
axis plays an important role in OVX mice. Bone-forming osteoblasts are restored by maintaining phosphorylation of
eIF2α, and bone-resorbing osteoclasts are regulated by inhibiting NFATc1 and Rac1 GTPase.
Introduction
Osteoporosis is one of the common skeletal diseases,
which presents a systemic impairment of bone mass and
micro-architecture. Its medical and socioeconomic
impacts, particularly those with postmenopausal osteo-
porosis in the aging population, are expected to sharply
increase1. Postmenopausal osteoporosis can be treated by
a variety of drugs, including anti-resorptive agents, ana-
bolic agents, and emerging monoclonal therapies targeted
to sclerostin2–5. None of them, however, provide an ideal
therapeutic option because of their side effects and/or
limited efficacy.
It is recently reported that the stress to the endoplasmic
reticulum (ER) is closely related to the progression of
skeletal disorders, including osteoporosis6. The ER stress
is a general term with varying stress sources that impede
the regular ER function7. Its evolutionarily conserved
pathway leads to the unfolded protein response (UPR)8, in
which protein kinase-like endoplasmic reticulum kinase
(PERK) acts as a sensor for accumulation of unfolded
proteins in the ER lumen of mammalian cells. It phos-
phorylates the subunit of the translation initiation factor,
eukaryotic translation initiation factor 2 alpha (eIF2α),
which suppresses general protein production except for
the selective stress responsive factors such as activating
transcription factor 4 (ATF4)9. Our previous study
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indicated that the ER stress plays an important role in the
development of disuse osteoporosis10. In postmenopausal
osteoporosis, the common type of osteoporosis, the
mechanism by which the ER stress regulates bone
homeostasis has not been elucidated.
Autophagy is a process of disassembling cellular com-
ponents to cope with various cellular malfunctions,
including UPR11,12. It is an intracellular degradation
mechanism in eukaryotic cells that transports damaged
cytoplasmic components to a lysosome for degradation
and recycling13. Autophagy is reported to be involved in
the regenerative function of mesenchymal stem cells
(MSCs) in bone marrow, as well as the progression of
osteoporosis14. Previous studies have shown that defi-
ciency in autophagy in osteoblasts decreases their
mineralizing capacity and leads to a low bone mass phe-
notype. Particularly, the autophagy proteins, Atg7, is
needed for mineralization of an osteoblastic cell line15. Its
deficiency impedes osteoblast mineralization, while its
reconstitution is shown to restore skeletal balance16.
However, the role of autophagy and Atg7 in post-
menopausal osteoporosis remains unclear.
Salubrinal is a 480-Da synthetic agent (C21H17Cl3N4OS),
which is known to inhibit the de-phosphorylation of
eIF2α17. Its effects on the differentiation of bone-marrow-
derived cells to osteoclasts and osteoblasts, is not well
understood. Furthermore, the mechanism eIF2α interacts
with Rho family GTPases such as Rac1, which play
important roles in bone formation and resorption18,19,
remains elusive.
An ovariectomized (OVX) mouse model mimics the
increased bone turnover induced by menopause in
humans20,21. Herein, we investigated the effects of
administration of salubrinal to the OVX mice, with a
focus on salubrinal’s dual role in regulating osteoblasts
and osteoclasts. We also evaluated the effects of salubrinal
in vitro using primary bone-marrow-derived cells, as well
as osteoblastic and pre-osteoclastic cell lines.
Materials and methods
Animals and agents
Animal use was approved by the Ethics Committee at
Tianjin Medical University. We used 123 C57BL/6 female
mice in total (~16 wks, Animal Center of Academy of
Military Medical Sciences, China). Under pathogen-free
conditions, 4–5 mice were housed per cage, and they were
maintained at 25 °C on a 12-h light/dark cycle, with
standard rodent chow and water ad libitum.
We purchased a murine RANKL (receptor activator of
nuclear factor kappa-B ligand) and murine M-CSF
(macrophage-colony stimulating factor) from Pepro-
Tech, and Dulbecco’s Modified Eagle’s Medium (DMEM),
Minimum Essential Medium Alpha (MEM-α), fetal
bovine serum (FBS), penicillin, streptomycin, and trypsin
from Invitrogen (Carlsbad, CA, USA). Other agents were
obtained from Sigma (St. Louis, MO, USA) unless
otherwise stated.
Cell culture
MC3T3-E1 cells were obtained from Chinese Academy of
Sciences Cell Bank. MC3T3-E1 cells differentiation were
initiated in α-MEM containing 10% FBS, 100U/mL peni-
cillin, 100 μg/mL streptomycin, 10mM β-glycerophosphate,
and 50 μg/mL ascorbic acid22,23. ALP and Alizarin Red
S staining was conducted to confirm osteoblasts before
following experiment.
OVX mouse model
The mice were randomly divided into three groups:
sham control group (Sham, n= 41), OVX group (OVX,
n= 41), and salubrinal-treated OVX group (OVX+ Sal,
n= 41). Anesthesia was induced using 1.5% isoflurane
(IsoFlo, Abbott Laboratories) with a rate of 0.5–1.0 L/min.
After shaving the hair in the dorsal mid-lumbar area, the
skin was cleaned and a 20-mm midline dorsal skin inci-
sion was made. After excision of a pair of ovaries, the
wound was closed by suturing24,25. The sham control
mice received the same procedure but no removal of the
ovaries. In 4 weeks, the OVX+ Sal group was given daily
subcutaneous injection of salubrinal (Tocris Bioscience).
The vehicle was 49.5% PEG400 with 0.5% Tween 80, and
salubrinal’s dose was 1 mg/kg body weight. The OVX
group was given an equal volume of vehicle10. Mice were
sacrificed in week 8.
Bone mineral density (BMD) and bone mineral content
(BMC)
BMD (g/cm2) and BMC (g) were determined for a
whole body on live mice, lumbar spines, femurs, and tibia
using peripheral dual-energy X-ray absorptiometry
(pDEXA)26, and ROI analysis was conducted.
Micro-computed tomography
A Scanco vivaCT 40 (Scanco Medical AG, Bassersdorf,
Switzerland) was employed for micro-computed tomo-
graphy (µCT) as previously reported27. Using 6-μm pixel
size, we set an X-ray source at 60 kV and scanned the
excised left distal metaphysis of the femurs. We focused
on a ~0.5 mm proximal region in the most distal part of
the growth plate. Base on three-dimensional (3D) images,
we determined parameters such as BV/TV (bone volume
fraction, %), Tb.N (trabecular number, 1/mm), Tb.Th
(trabecular thickness, μm), and Tb.Sp (trabecular bone
spacing, μm).
Histology and histomorphometry
The femur was fixed in 10% neutral buffered formalin
for 2 days, followed by decalcification in 14% EDTA for
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2 weeks. The paraffin-embedded samples were cut into 5-
μm-thick coronal sections and stained with hematoxylin-
eosin (H&E). On the proximal side of the growth plate, we
determined B.Ar/T.Ar (bone area/total area) within
2.6-mm2 sample area.
The differentiation and maturation of osteoclasts were
evaluated with tartrate-resistant acid phosphatase (TRAP)
staining28. We also employed MacNeal’s staining for
identification of osteoblasts29. The number of osteoblasts
was normalized using the trabecular bone surface, and
histomorphometry of the distal metaphysis of the femur
were performed. All samples were blinded for quantitative
analysis.
For evaluation of bone formation, we conducted calcein
labeling with intraperitoneal injection of 10 mg/kg calcein
on day 7 and 2 days prior to sacrifice30,31. The femur
samples were prepared in LR white acrylic resin, and 15-
μm sections were cut for determination of dynamic
parameters, such as mineral apposition rate (MAR;
interlabel width/day), mineralizing surface/bone surface
[MS/BS: (double labeled surface+ single-labeled sur-
face/2)/BS], and bone formation rate [BFR/BS: MAR ×
MS/BS/100]32.
Electron microscopic analysis
The femurs and MC3T3-E1 osteoblast-like cells were
imaged using electron microscopy33–35. After sample
fixation, decalcification was conducted in 14% EDTA for
2 weeks. Post-fixation was conducted in 1% osmium
tetroxide for 1 h. After dehydration, they were infiltrated
in epoxypropane, followed by embedding in EPON812.
We generated ~50 nm sections and imaged with a model
7500 electron microscope (Hitachi). Fifty sections were
made for each sample and the number of autophagic
vacuoles was identified. A MEGAVIEW camera was used
to capture the images of osteoblasts. The rough ER area
percentages in the osteoblastic cytoplasm and the number
of intracellular autophagosomes in every 10 fields were
determined using Cellsense standard software.
Immunohistochemistry assay
For immunohistochemical analysis, femoral sections
were incubated with primary antibodies against ATF4 and
CHOP (Cell Signaling, Danvers, MA, USA) at 4 °C over-
night. An immunohistochemical kit and 3, 3′-diamino-
benzidine (DAB) (ZSGB-BIO, Beijing, China) substrate kit
were used according to the manufacturer’s protocol.
Approximately 6–8 sections were obtained from each
sample, and the same region was analyzed from all
samples36,37.
ELISA assay
Blood samples were collected from mice. A bone for-
mation markers, amino terminal propeptide of type I
collagen (PINP), and a bone resorption marker, tartrate-
resistant acid phosphatase type 5b (TRACP-5b), were
detected according to the instructions of manufacturer16,38.
Immunofluorescence analysis of LC3
Immunofluorescence analysis was conducted as descri-
bed previously39. MC3T3-E1 cells were cultured with
DMSO (vehicle), 5 μM salubrinal, 100 ng/ml tunicamycin,
3-MA, or 200 nM rapamycin for the positive control for
48 h. They were incubated with LC3 antibody for labelling
autophagosomes, followed by incubation with fluorescent
antibody in dark. DAPI was employed to counterstain the
nuclei. The experiment was conducted in triplicate.
CFU-F (colony-forming unit-fibroblasts), CFU-OBL (colony-
forming unit-osteoblasts), and osteoblast mineralization
We conducted the CFU-F assay and evaluated the col-
ony formation ability of fibroblast-like MSCs40,41. We
counted CFU-F colonies with more than 50 cells, and we
excluded the clusters that did not present fibroblast-like
morphology.
In the CFU-OBL assay, we isolated bone-marrow-
derived cells and plated them at 2 × 106 cells/ml in
osteogenic differentiation medium (MesenCult prolifera-
tion kit)29. The medium was exchanged every other day
for 2 weeks, followed by alkaline phosphatase (ALP)
staining including counterstaining with Mayer's
Hematoxylin.
A mineralization assay with primary osteoblasts was
conducted42. After fixation in 100% ethanol on ice for 1 h,
cells were stained with 1% Alizarin red S dye (pH 4.1) and
rinsed five times with deionized water.
Osteoclast differentiation from bone-marrow-derived cells
We harvested bone-marrow-derived cells from the
iliac, femur, and tibia in Iscove’s MEM (Gibco-Invitro-
gen)43. Cells were isolated using low-density gradient
centrifugation, and grown in α-MEM, containing 10%
FBS, 20 ng/ml RANKL, and 30 ng/ml M-CSF. The
medium was exchanged on day 4 with α-MEM con-
sisting of 10% FBS, 60 ng/ml RANKL, and 30 ng/ml M-
CSF, and cells were cultured for 3 additional days44. We
evaluated osteoclast differentiation using bone-marrow-
derived cells in the presence and absence of salubrinal45,
and evaluated adherent cells using a tartrate-resistant
acid phosphate (TRAP)-staining kit on day 6. We
identified TRAP-positive osteoclasts with more than
three nuclei, and determined the surface area with
mature osteoclasts.
Osteoclast migration and adhesion
Using a transwell assay, we evaluated migration of
osteoclasts as described previously43. We also evaluated
osteoclast adhesion using precursor cells using a
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vitronectin-coated plate44. After 30 min incubation, cells
were rinsed and fixed with 4% paraformaldehyde, and the
number of cells adherent to αvβ3 was counted after crystal
violet staining.
Quantitative PCR and western blot analysis
Quantitative PCR was conducted for RAW264.7 pre-
osteoclast cells and MC3T3-E1 osteoblast-like cells (C14
clone), which were grown in MEM with 10% FBS and
antibiotics46. Osteoclastogenesis of RAW264.7 cells were
induced by incubation with 20 ng/ml of RANKL. The PCR
primers were: NFATc1 (5′-GGT GCT GTC TGG CCA
TAA CT-3′ and 5′-GCG GAA AGG TGG TAT CTC AA-
3′); TRAP (5′-GCA AAT ACC CAC AGT TCC GC-3′
and 5′-AAG ACT CCC AGC GTC ACG TC-3′); cathe-
psin K (5′-CAG CTT CCC CAA GAT GTG AT-3′); and
GAPDH (5′-TGC ACC ACC AAC TGC TTA G-3′ and
5′-GGA TGC AGG GAT GAT GTT C-3′) as an internal
control.
For western blot analysis, we isolated proteins from
femurs, bone-marrow-derived cells, RAW264.7 cells, and
MC3T3-E1 cells. Bilateral femurs were obtained and tri-
turated in liquid nitrogen. Briefly, the harvested samples
were placed in a pre-cooled mortar, and liquid nitrogen
was added for condensing the sample. After liquid
nitrogen volatilization, the nucleus pulposus was ground
into a powder using a pestle. During grinding, liquid
nitrogen was added until the sample had been sufficiently
ground. Antibodies specific to Bip (Affinity BioReagents),
cathepsin K, NFATc1, and TRAP (Santa Cruz), ALP
(Proteintech), eIF2α, p-eIF2α (Cell Signaling), Rac1 (Mil-
lipore), Atg7 (Abcam), LC3, p62 (Medical & Biological
Laboratories), and β-actin (Sigma) were employed.
Fluorescence-based osteoclast activity assay
We evaluated osteoclast activity using a bone resorption
assay kit (Cosmo Bio). In brief, RAW264.7 cells were cul-
tured for 7 days on a plate coated with fluoresceinamine-
labeled calcium phosphate in the presence and absence of
RANKL and salubrinal. Fluorescence intensity of the culture
medium was measured using excitation/emission wave-
lengths at 485/535 nm.
Knockdown of eIF2α, Atg7, and Rac1 by siRNA
RNA interference was conducted to osteoblasts differ-
entiated from bone-marrow-derived cells, MC3T3-E1
cells and RAW264.7 cells using siRNAs specific to
eIF2α, Atg7, and Rac1 (Life Technologies). The selected
target sequences were: Atg7, 5′-AUU AGA GGG AUG
CUC UCA GTT-3′; eIF2α, 5′-AAG CUA CUU CAA UAU
CUG CTT-3′; Rac1, 5′-GCA UUU CCU GGA GAG UAC
A -3′; and non-specific control (Scrambled siRNA 5′-
ACG UGA CAC GUU CGG AGA TTA-3′, Life Tech-
nologies). Cells were transiently transfected using
Lipofectamine RNAiMAX in Opti-MEM I medium (Life
Technologies). The transfection medium was replaced in
6 h, and the silencing efficiency was evaluated using
Western blot in 48 h after transfection according to the
manufacturer’s instruction.
Fluorescence resonance energy transfer (FRET) imaging
To evaluate the effect of salubrinal on Rac1 activity, live
cell imaging was conducted using a Rac1 FRET biosensor
in RAW264.7 cells. Activation of Rac1 results in con-
formational changes of the biosensor that shift emission
signal from cyan fluorescent protein (CFP) to yellow
fluorescent protein (YFP). Rac1 activity is thus evaluated
by an intensity ratio of YFP/CFP in individual cells47,48.
We acquired fluorescent time-lapse images at an interval
of 5 min, and FRET images (YFP/CFP emission ratio)
were depicted by NIS-Elements software (Nikon).
Statistical analysis
Data were shown as mean ± SEM, and statistical sig-
nificance was tested using one-way ANOVA. We con-
ducted a post-hoc test using Fisher’s protected least
significant difference. In FRET data analysis, we deter-
mined the mean activation level of Rac1 at each time
point and conducted one-way ANOVA with Dunnett’s
post-hoc test. Statistical significance of the salubrinal-
injected sample to the control sample was examined using
a paired t-test. All comparisons were two-tailed and sta-
tistical significance was assumed at P < 0.05. The single,
double, and triple asterisks represent P < 0.05, 0.01, and
0.001, respectively.
Results
Attenuation of OVX-driven effects in salubrinal-
administered mice
Compared to the sham group, OVX mice significantly
decreased BMD and BMC not only in the lumbar spine,
but also in the femur and tibia. Compared to OVX mice,
salubrinal-treated OVX mice exhibited a statistically
significant increase in BMD and BMC not only in the
lumbar spine, but also in the femur and tibia (all P <
0.001; Fig. 1a, b).
Compared to the sham group, micro-CT imaging of the
distal metaphysis of the femurs (Fig. 1c) indicated that the
values of BV/TV (P < 0.001), Tb.N (P < 0.01), and Tb.Th
(P < 0.05) in OVX mice were decreased, with an increase
in Tb.Sp (P < 0.05). In addition, BV/TV was altered from
18.41 ± 1.87% (OVX) to 24.46 ± 2.57% (OVX+ Sal) (P <
0.05; Fig. 1d). The trabecular number was elevated by
27.35% from 4.68 ± 0.49 (OVX) to 5.96 ± 0.42 (OVX+
Sal) (P < 0.05; Fig. 1e), and the femoral trabecular thick-
ness was increased by 22.19% with salubrinal (P < 0.05;
Fig. 1f). However, the femoral trabecular spacing was
decreased by 23% with salubrinal (P < 0.001; Fig. 1g).
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To evaluate salubrinal’s effect on bone architecture, the
bone area/total area (B.Ar/T.Ar) in the distal metaphysis
of the femurs was determined using H&E staining
(Fig. 1h). OVX mice presented a reduction in B.Ar/T.Ar
compared with the sham control mice (P < 0.001; 32.05 ±
1.50% in the sham control mice, and 19.31 ± 0.82% in the
OVX mice). However, administration of salubrinal sig-
nificantly restored B.Ar/T.Ar (P < 0.001; 25.50 ± 1.03% in
salubrinal-treated OVX mice).
To evaluate bone resorption and bone formation, serum
biomarkers were used. Compared to the sham group, we
observed a reduction in PINP (P < 0.001; Fig. 1i), a cir-
culating marker of bone formation, and an increase in
TRACP-5b, a bone resorption marker, in serum from
OVX mice (P < 0.01; Fig. 1j). Administration of salubrinal
significantly restored OVX-induced decrease in PINP
(P < 0.001; Fig. 1i) and the increase in the serum level of
TRACP-5b (P < 0.05; Fig. 1j).
Fig. 1 Effects of ovariectomy and salubrinal on BMD, BMC, micro-architecture, serum PINP, and TRACP 5b. a, b Suppression of OVX-induced
reduction of BMD and BMC, in the lumbar spine, femur, and tibia. Salubrinal increased BMD and BMC, compared to OVX in the lumbar spine, femur
and tibia. c–f Representative µCT reconstructed femurs in the longitudinal (top) and transverse (bottom) cross-sections after 4-week treatment with
salubrinal (c), salubrinal-driven suppression of OVX-induced loss of femoral BV/TV (d), femoral trabecular number (Tb.N) (e), and femoral trabecular
thickness (Tb.Th) (f), Salubrinal-driven suppression of OVX-induced increase in femoral trabecular spacing (Tb.Sp) (g) (Bar= 500 μm). h B.Ar/T.Ar ratio
in the distal metaphysis of the femurs (Bar= 500 μm). Trabecular bones were indicated by the arrows. i, j Serum PINP and TRACP 5b analyses (n= 5).
The asterisks (*, **, and ***) represent statistical significance at P < 0.05, P < 0.01, and P < 0.001, respectively (n= 12).
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Salubrinal-driven differentiation of osteoblast in vivo and
in vitro
In the present mouse model, we examined the para-
meters for bone formation in the long bones using calcein
labeling. Compared to the sham group, OVX reduced BFR
in cancellous bone by the combination of reduction in
MS/BS and MAR (all P < 0.001). However, salubrinal
restored BFR (P < 0.001) in cancellous bone by combined
promotion of MS/BS (P < 0.01) and MAR (P < 0.001;
Fig. 2a–d).
Fig. 2 Effects of salubrinal on osteoblast differentiation. a–d Calcein-labeled cortical femoral bones. Mineral apposition rate (MAR), MS/BS and
BFR/BS was calculated (Bar= 100 μm). e, f Salubrinal-induced increase in the osteoblast numbers in OVX mice. The microphotographs represent the
three groups of MacNeal’s staining (Bar= 50 µm). Osteoblasts, located on the trabecular bone surface, were indicated by the arrows. g, h Comparison
of CFU-F. i, j Comparison of CFU-OBL. Bone-marrow-derived cells were isolated from three groups of mice (Sham, OVX and salubrinal-injected OVX
mice) (Bar= 2 cm). k Osteoblast mineralization (Alizarin Red staining) were determined in bone-marrow stem cells after they were cultured in the
osteoblast inducing medium (Bar= 2 mm). The representative photographs are shown. The asterisks (** and ***) represent statistical significance
at P < 0.01 and P < 0.001, respectively (n= 20).
Li et al. Cell Death and Disease          (2019) 10:921 Page 6 of 15
Official journal of the Cell Death Differentiation Association
MacNeal’s staining revealed that compared to the sham
group, OVX mice reduced the number of osteoblasts on a
trabecular bone surface (P < 0.001). However, adminis-
tration of salubrinal markedly elevated the number of
osteoblasts (P < 0.001; Fig. 2e, f). Cells derived from the
salubrinal-treated OVX mice elevated the number of
colonies in CFU-F (P < 0.01 for OVX vs OVX+ Sal) and
CFU-OBL (P < 0.001 for OVX vs OVX+ Sal), compared
to cell cultures derived from the sham-operated and OVX
mice (Fig. 2g–j). The result with alizarin red staining
showed that the OVX group decreased the number of
mineralized nodules compared to the sham control group,
while salubrinal-treated mice promoted mineralization of
osteoblasts (Fig. 2k).
Salubrinal-driven suppression of ER stress and activation
of autophagy in osteoblasts
Electron microscopy was employed to evaluate mor-
phology of the ER in osteoblasts in the distal metaphysis of
the femurs. In OVX animals, we observed significant
expansion of the rough ER and a decrease in the number
of ribosomes on the ER membrane. Compared to the sham
group (8.97 ± 1.09%), OVX mice (19.65 ± 2.71%) increased
the percentage of the rough ER area (P < 0.01), while
salubrinal-treated OVX mice exhibited restoration of the
expanded rough ER (11.40 ± 0.69%, P < 0.01; Fig. 3a).
Autophagy is characterized morphologically by the
accumulation of acidic vesicular (AVs), and we examined
AVs of osteoblasts in the distal metaphysis of the femurs
using transmission electron microscopy. The number of
autophagosomes in the OVX group was fewer than that in
the sham group, but the number of osteoblast AVs was
significantly increased in the salubrinal-treated group
(P < 0.001; Fig. 3b).
Promotion of osteogenesis by regulating ER stress and
autophagy
IHC staining of femur sections showed that the levels of
ATF4 was decreased in osteoblasts of OVX mice com-
pared to those of the sham mice, while the level of CHOP
was increased. In the salubrinal-treated group, the
expression of ATF4 was increased and the level of CHOP
was decreased (Fig. 3c, d).
Western blot analysis showed that salubrinal increased
the levels of Bip, p-eIF2α, LC3II/I, and ALP, while it
decreased p62 in the femur samples (Fig. 3e and Sup-
plementary Fig. S1). To investigate the role of eIF2α in
salubrinal’s action, the markers for the ER stress and
autophagy were examined in osteoblasts differentiated
from bone marrow cells with and without transfection of
eIF2α siRNA. The result showed that transfection of
eIF2α siRNA suppressed salubrinal’s effect on p-eIF2α,
LC3II/I, p62, and ALP in bone marrow cells (Fig. 3f and
Supplementary Fig. S2).
Induction of LC3 through regulating Atg7
To further evaluate the mechanism by which salubrinal
regulates autophagy in the differentiated osteoblasts from
MC3T3-E1 cells (Supplementary Fig. S3a, b), we eval-
uated the effect of siRNA specific to Atg7 (Fig. 4a). We
also employed tunicamycin (ER stress inducer), salubrinal,
3-MA and rapamycin (inhibitor and stimulator of
autophagy, respectively), and detected the level of an
autophagy marker protein, LC3.
Compared to the vehicle group, the number of LC3
puncta was decreased after treatment with tunicamycin,
while the autophagic puncta was significantly increased
after salubrinal treatment. As expected, 3MA decreased
LC3, and rapamycin increased LC3. When MC3T3-E1
cells were treated with siRNA specific to Atg7, salubrinal-
driven alteration of LC3 was diminished compared to
non-specific controls. Taken together, the observed
expression pattern of LC3 was consistent with the role of
salubrinal (Fig. 4b, c). Compared to the vehicle, salubrinal
and rapamycin (P < 0.05) promoted the LC3 puncta, while
3MA significantly inhibited the autophagic fluorescent
signal (P < 0.001; Supplementary Fig. S4a, b).
Compared to the vehicle group, the number of AVs was
decreased after treatment with tunicamycin, while the
autophagosomes were significantly increased after salu-
brinal treatment. However, 3MA decreased the number of
autophagosomes, and rapamycin increased them. When
cells were treated with siRNA specific to Atg7, salubrinal-
driven alteration of autophagosomes was significantly
diminished compared to the cells treated with non-
specific control siRNA. Taken together, the observed
expression pattern of autophagosomes was consistent
with the role of salubrinal (Fig. 5a, b).
Compared to the vehicle group, western blot analysis
showed that tunicamycin induced endoplasmic reticulum
stress, which significantly changes expression of Bip,
eIF2α, ATF4, and CHOP, while salubrinal restored
expression of Bip, eIF2α, ATF4, and CHOP. The result
showed that transfection of Atg7 siRNA slightly blocked
the effect of salubrinal on expression of Bip, eIF2α, ATF4,
and CHOP. While partially silencing Atg7, the expression
of LC3 and p62 was not significantly attenuated by reg-
ulating the expression of the autophagy-associated pro-
tein Atg7. These results indicated that salubrinal
promoted eIF2α-driven osteoblast autophagy through
regulating the expression of Atg7 (Fig. 5c and Supple-
mentary Fig. S5).
Bone resorption and osteoclastogenesis
Compared to the sham control, TRAP staining of the
distal metaphysis of the femurs showed that the osteoclast
surface (Oc.S/BSf) was significantly increased in OVX
mice (P < 0.001). However, the elevated ratio was mark-
edly reduced by salubrinal (P < 0.001; Fig. 6a).
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Osteoclast formation was conducted using bone-
marrow-derived cells. The surface area (index of mature
multinucleated osteoclasts formation) of mature osteoclasts
was increased in the OVX mice, whereas a significant
reduction was observed in the osteoclast surface area of
salubrinal-treated OVX mice (both P < 0.001; Fig. 6b).
Osteoclast function was evaluated through migration
and adhesion assays using bone-marrow-derived cells.
The OVX group elevated both migration (P < 0.001;
Fig. 6c) and adhesion (P < 0.05; Fig. 6d), while salubrinal-
treated OVX mice significantly attenuated both migration
(P < 0.001; Fig. 6c) and adhesion (P < 0.01; Fig. 6d).
Fig. 3 Regulation of ER stress and autophagy by salubrinal. a, b Electron micrographs, indicating that ultrastructural changes of the rough
endoplasmic reticulum (ER) and autophagy in osteoblasts from OVX mice after treatment with salubrinal. Quantitative analyses of the rough ER areas
in the cytoplasm of osteoblasts. The percentages of the rough ER area were measured. The rough ER were indicated by the red arrows (a).
Representative electron micrographs of accumulation of autophagic vacuoles in osteoblast cells. Quantitation of autophagosomes in osteoblasts. The
autophagosomes were indicated by the red arrows (b). Of note, N indicated the nucleus. Tb indicated the trabecular bone, and AVs indicated the
acidic vesicular (Bar= 2 μm on the upper, and Bar= 1 μm on the bottom). c, d Immunohistochemistry staining of ATF4 and CHOP of osteoblasts in
femurs were conducted (Bar= 50 μm). e Representative images of Western blot in three different groups in vivo. The levels of Bip, p-eIF2α, LC3II/I,
p62 and ALP were shown. f Partial silencing of eIF2α protein level by eIF2α siRNA, and protein expression of p-eIF2α, LC3II/I, p62, and ALP in
osteoblasts differentiated from bone marrow cells. The experiment was conducted in triplicate. The asterisks (*, **, and ***) represent P < 0.05,
P < 0.01, and P < 0.001, respectively (n= 9).
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Dose-dependent effect on osteoclast differentiation
To further examine salubrinal’s effects on the matura-
tion of osteoclasts, salubrinal was applied at three doses
(1, 2, and 5 µM) and 2 phases (on days 0 and 4) to bone-
marrow-derived cells isolated from OVX mice. Compared
to the vehicle control, salubrinal for 6 days (days 0–6)
significantly decreased the surface area covered by
multinucleated osteoclasts (P < 0.001 for 0 µM vs 1 µM,
P < 0.05 for 1 µM vs 2 µM; and P < 0.001 for 2 µM vs
5 µM). To test the effects of salubrinal on the late devel-
opment, salubrinal was administered on days 4–6. This
shorter incubation with salubrinal was also capable of
inducing salubrinal-driven decrease in the osteoclastic
surface area in a dosage-dependent manner (P < 0.05 for
Fig. 4 Induction of the LC3 puncta through regulating Atg7 by salubrinal. a Partial silencing of Atg7 protein level by Atg7 siRNA.
b Representative immunofluorescence images of LC3 in MC3T3-E1 cells from different groups. (blue: DAPI; red: LC3+ cells; Tm: tunicamycin; Tm+ Sal:
tunicamycin+ salubrinal; Tm+ 3-MA: tunicamycin+ 3-MA; Tm+ rapa: tunicamycin+ rapamycin; 400×, Bar= 50 μm). c Quantification of LC3 puncta
per cell is shown. The experiment was conducted in triplicate. The asterisks (*, **, and ***) represent P < 0.05, P < 0.01, and P < 0.001, respectively.
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0 µM vs 1 µM, and P < 0.001 for 2 µM vs 5 µM; Fig. 6e).
This timeline was also able to provide a significant decrease
in osteoclast formation in dosage-dependent manner in the
early and late phases in salubrinal-treated OVX mice.
We examined salubrinal’s effect using pre-osteoclast
cells isolated from OVX mice. Salubrinal provided a
slower migration rate (P < 0.001; Fig. 6f), and it induced a
significant reduction in cell adhesion (P < 0.001; Fig. 6g).
Effects of salubrinal on NFATc1 and Rac1
To gain insight into the mechanism underlying the
action of salubrinal on osteoclast development, migration,
and adhesion, the effect of salubrinal on RAW264.7
monocyte/macrophage cells was evaluated. Western blot
analysis showed that salubrinal decreased the protein level
of the transcription factor critical for osteoclast differ-
entiation, NFATc1, in a dose-dependent fashion (Fig. 7a).
Administration of salubrinal (5, 10, and 20 μM) reduced
RANKL-driven elevation of NFATc1 mRNA level in a
dose-dependent manner (Fig. 7b). Furthermore, a
fluorescence-based osteoclast activity assay showed that
RANKL-driven increase in osteoclast activity was
decreased by administration of salubrinal (P < 0.05 for
20 µM vs 0 µM; Fig. 7c).
Fig. 5 Regulation of ER stress and autophagy through Atg7 by salubrinal. a, b Representative electron micrographs of accumulation of
autophagic vacuoles in the differentiated osteoblasts from MC3T3-E1 cells. Red arrow indicated autophagosomes. c Representative images of
Western blot in different groups in vitro. The levels of Bip, eIF2α, ATF4, CHOP, Atg7, LC3II/I, and p62 were shown. The experiment was conducted in
triplicate. The asterisks (*, **, and ***) represent P < 0.05, P < 0.01, and P < 0.001, respectively.
Li et al. Cell Death and Disease          (2019) 10:921 Page 10 of 15
Official journal of the Cell Death Differentiation Association
Fig. 6 Effects of salubrinal on osteoclast development. a The osteoclast number in the OVX group was significantly suppressed by salubrinal
injection. The representative photographs are shown (Bar= 200 μm). TRAP-positive cells in the distal metaphysis of the femurs, red color, indicated
by the arrows. b Osteoclast formation was conducted using bone-marrow-derived cells. Coverage area of mature osteoclasts. c, d Osteoclast function
was evaluated through migration and adhesion assays. Migration assay of osteoclasts (c). Adhesion assay of osteoclasts (d). e Coverage area of
mature osteoclasts. Salubrinal was applied at 3 doses (1, 2, and 5 µM) and 2 phases (on days 0 and 4) to bone-marrow-derived cells isolated from OVX
mice. Four pairs of images on the bottom show representative osteoclasts stained with TRAP. (Bar= 200 µm). Experiments were conducted in
triplicates. Five fields were counted per well. Upper panel: Effects of in vitro salubrinal administration during days 0–6. Bottom panel: Effects of in vitro
salubrinal administration during days 4–6. f Salubrinal-induced reduction in the migration of osteoclasts in both Sham-derived cells and OVX-derived
cells. g Salubrinal-induced suppression of the adhesion of osteoclasts in both Sham-derived cells and OVX-derived cells. The asterisks (*, **, and ***)
represent statistical significance at P < 0.05, P < 0.01, and P < 0.001, respectively (n= 12).
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To examine the effect of salubrinal on Rac1 GTPase
activity in RAW264.7 cells, we used FRET-based live cell
imaging. The emission ratio of YFP/CFP was reduced after
administration of 10 and 20 μM salubrinal, supporting
salubrinal’s inhibitory role in Rac1 activation (Fig. 7d, e).
When RAW264.7 cells were transfected with siRNA spe-
cific to eIF2α, salubrinal-driven downregulation of Rac1
activity was significantly diminished (P < 0.05; Fig. 7f, g).
Fig. 7 Effects of salubrinal on NFATc1 and Rac1. a Dose-dependent decrease in NFATc1 in RAW264.7 cells by 5–20 μM salubrinal. b Reduction of
the mRNA levels of NFATc1 in RAW264.7 cells by 5–20 μM salubrinal. c Reduction in fluorescence-based osteoclast activity by salubrinal
administration. d, e YFP/CFP emission ratios were averaged over the whole cell and normalized to time-10 min (10 min before Sal treatment).
(bar= 10 μm). f Partial silencing of eIF2α protein level by eIF2α siRNA. g The activity of Rac1 in response to 20 μM salubrinal. NC= treatment with
non-specific control siRNA. h, i Partial silencing of Rac1 protein level by Rac1 siRNA, and protein expression of NFATc1, TRAP, and cathepsin K. NC=
treatment with non-specific control siRNA. j, k Relative mRNA levels of NFATc1, TRAP, and cathepsin K in response to Rac1 siRNA. TRAP and cathepsin
K expressions are reduced by Rac1 siRNA, but NFATc1 expression remains unchanged. The experiment was conducted in triplicate. The asterisks
(*, **, and ***) represent statistical significance at P < 0.05, P < 0.01, and P < 0.001, respectively.
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Using siRNA specific to Rac1 in RAW264.7 cells, the
role of Rac1 in expression of NFATc1, TRAP, and
cathepsin K was examined. The result showed that TRAP
and cathepsin K were downregulated by salubrinal. Con-
sistent with salubrinal’s effects on those protein levels, a
partial silencing of Rac1 suppressed RANKL-driven
upregulation of TRAP mRNA and cathepsin K mRNA
but did not alter the level of NFATc1 mRNA (Fig. 7h–l).
Discussion
Our data showed that salubrinal prevented bone loss by
promoting osteoblast differentiation and inhibiting
osteoclast development in OVX mice. Salubrinal admin-
istration markedly suppressed OVX-induced bone loss in
the lumbar spine, femur, and tibia. Consistent with its
effects on BMD and BMC, salubrinal improved OVX
symptoms, including a decrease in BV/TV, trabecular
number, trabecular thickness and serum PINP, as well as
an increase in trabecular spacing, body weight and serum
TRAP-5b. Similarly, salubrinal effectively prevented
OVX-driven inhibition of mineral apposition rates, MS/
BS and BFR/BS.
This study demonstrates that the ER stress-autophagy
axis plays a critical role in the mouse model of post-
menopausal osteoporosis. Electron microscopy showed
that OVX-induced enlargement of the rough ER and a
decrease in the ribosome population on the osteoblastic
ER membrane. Salubrinal suppressed OVX-induced
expansion of the rough ER. IHC staining showed that
salubrinal attenuated expression of ATF4 and CHOP in
OVX mice. In bone marrow cells isolated from OVX
mice, we also observed a decrease in the ratio of LC3II/I,
and accumulation of p62. Immunofluorescence, electron
microscopy analysis, and western blot analysis of LC3
indicated that salubrinal promoted autophagy of osteo-
blasts by regulating the expression of Atg7. LC3II is a
marker of autophagic vacuoles and both LC3I and LC3II
are biomarkers in monitoring autophagy49, and
p62 serves as an indicator of autophagic degradation50.
Collectively, the in vitro and in vivo results showed that
salubrinal restores bone homeostasis in postmenopausal
osteoporosis via simultaneous regulation of the ER stress
and autophagy in bone-marrow-derived cells and
osteoblasts.
When the ER stress becomes excessive, cells may
initiate autophagy that potentially induces large-scale
cellular degradation51. Autophagy may serve as a pro-
survival mechanism in response to excessive cellular
stress52. Autophagy is characterized morphologically by
the accumulation of acidic vesicular, and we observed
that the number of AVs in the OVX group were fewer
than that in the sham group. The result showed that
osteoblastic AVs were significantly increased in the
salubrinal-treated group.
The results of CFU-F and CFU-OBL were consistent
with salubrinal-driven promotion of bone formation in
OVX mice. The increase in CFU-F by salubrinal suggested
MSCs proliferation is stimulated in bone-marrow-derived
cells, while the increase in ALP-positive cells in CFU-OBL
indicated enhancement of osteoblast development. Ali-
zarin red staining showed that the salubrinal-treated OVX
mice promoted mineralization of osteoblasts. Salubrinal
preserves eIF2α phosphorylation as a selective inhibitor of
a phosphatase complex of eIF2α, protein phosphatase 1
(PP1)17,53. It is reported that the elevated level of p-eIF2α
can accelerate the healing of bone wounds and enhance
bone formation54–56. Salubrinal prevented apoptosis of
osteoblasts induced by glucocorticoids and the con-
comitant decrease in bone mass and bone formation57.
Our findings agree with this report, showing that salu-
brinal improves OVX-induced bone loss by regulating p-
eIF2α, ATF4, CHOP, and LC3. It also contributes to
suppress cellular stress, such as the stress to the ER,
radiation, and unloading, by reducing translational effi-
ciency in general.
Studies indicate that autophagy also plays an important
role in bone resorption by osteoclasts. It has recently been
observed in mice that pharmacological and genetic inhi-
bition of autophagy reduces osteoclastogenesis and bone
resorption, suppressing bone loss caused by ovariectomy
or glucocorticoid treatment58. However, whether salu-
brinal regulates the development of osteoclasts through
the regulation of autoregulation-associated protein Atg7
requires further study. Regarding the development of
osteoclasts in the OVX mice, subcutaneous injection of
salubrinal in vivo as well as incubation with salubrinal
in vitro suppressed the proliferation of pre-osteoclasts as
well as their differentiation to mature multinucleated
osteoclasts43. Western blot analysis revealed that salu-
brinal reduced the expression of NFATc1 in RANKL-
stimulated bone-marrow-derived cells as well as
RAW264.7 cells. Because of p-eIF2α in reducing transla-
tional efficiency, regulation of NFATc1 by salubrinal is
likely to be achieved at least in part at the level of trans-
lation56. Consistent with the previous study43, we
observed, that both the mRNA and protein levels of
NFATc1 were reduced by salubrinal. These results,
together with previous studies59, suggest a mechanism for
osteoclast regulation by salubrinal through p-eIF2α and
NFATc1. Further studies will establish other genes that
may mediate the response of NFATc1 to salubrinal
treatment.
Live cell imaging using RAW264.7 cells revealed that
salubrinal suppressed activity of Rac1 GTPase, which is
involved in various functions including cell migration.
Previous studies showed that salubrinal reduces pro-
liferation and migration of breast cancer cells in a murine
model of mammary tumor by eIF2α-mediated
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suppression of Rac1 GTPase18. Administration of salu-
brinal presented significant reduction in cell migration
and adhesion in RANKL-injected mice43. Our previous
study indicated that salubrinal inhibited migration and
adhesion of osteoclast in a disuse osteoporosis animal
model10. The previous study also demonstrated that
salubrinal prevented the glycosylation of Rac1 caused by
eIF2α signaling pathway60. Based on the result with eIF2α
siRNA, this downregulation was in part mediated by
eIF2α signaling. The observed result is consistent with
salubrinal’s action on inhibiting migration of pre-
osteoclast cells. Furthermore, RNA silencing with siRNA
specific to Rac1 showed that Rac1 also mediates
salubrinal-driven downregulation of TRAP and cathepsin
K although expression of NFATc1 is not directly regu-
lated by Rac1. This results demonstrate the potential of
salubrinal as a therapy for reversing bone loss from
osteoporosis. The mechanism of salubrinal was explored
on bone cells using FRET and RNA inhibition to identify
Rac1 GTPase as a mediator of its osteoclast suppression
separate from NFATc1.
This study demonstrates that salubrinal attenuates the
bone loss by regulating the ER stress-autophagy axis
through stimulating the expression of Atg7 of osteoblasts
and altering the proliferation and differentiation of
osteoclasts by regulating eIF2α, Rac1, and NFATc1
(Fig. 8). This study presented the possibility of a drug
therapy to prevent bone loss. The results herein utilizing
the OVX mouse model and primary bone-marrow-
derived cells, as well as cell line-based cultures, show
that salubrinal prevented OVX-associated symptoms
through stimulating osteoblasts development and inhi-
biting osteoclasts activity. Further analysis may focus on
the underlying mechanism of salubrinal’s action warrants
the possibility of a novel therapeutic strategy for post-
menopausal osteoporosis.
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